John E. Overall

Learn More
Controlled clinical trials in neuropsychopharmacology, as in numerous other clinical research domains, tend to employ a conventional parallel-groups design with repeated measurements. The hypothesis of primary interest in the relatively short-term, double-blind trials, concerns the difference between patterns or magnitudes of change from baseline. A simple(More)
This article is about a simple two-stage analysis that utilizes slope coefficients as the dependent variable for testing the significance of difference in mean rates of change in repeated measurement designs with missing data. The ANCOVA test on the doubly weighted slope coefficients provides power comparable to that of more complex maximum likelihood(More)
Recent contributions to the statistical literature have provided elegant model-based solutions to the problem of estimating sample sizes for testing the significance of differences in mean rates of change across repeated measures in controlled longitudinal studies with differentially correlated error and missing data due to dropouts. However, the(More)
Autocorrelated error and missing data due to dropouts have fostered interest in the flexible general linear mixed model (GLMM) procedures for analysis of data from controlled clinical trials. The user of these adaptable statistical tools must, however, choose among alternative structural models to represent the correlated repeated measurements. The fit of(More)
This paper examines the implications of the correlational structure of repeated measurements for three indices of change that can be used to evaluate treatment effects in longitudinal studies with scheduled assessment times and fixed total duration. The generalized least squares (GLS) regression of repeated measurements on time, which is usually reserved(More)
  • 1